tirzepatide and blindness Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Insights into the Mechanism of

View image online ( Wegovy is approved by the U.S

Given that GSH is a critical cellular antioxidant, most of the regulatory effects of GSH on cell signaling are ascribed to its role in redox homeostasis 28

Two years prior to presentation, the patient started treatment for obesity with duraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist

Peroxisome proliferator-activated receptor alpha (PPAR), a key nuclear transcription factor that regulates keratinocyte differentiation and epidermal lipid metabolism, is markedly downregulated in AD (Kuai et al., 2024), leading to impaired barrier integrity and defective lipid synthesis, which further supported by PPAR agonist-induced barrier restoration in ex vivo skin model (Majewski et al., 2021)